Adani Airport Holdings has terminated its ground handling concession agreements with Turkish firm Çelebi at Mumbai’s Chhatrapati Shivaji Maharaj International Airport and Ahmedabad’s Sardar Vallabhbhai Patel International Airport. This decision follows the Indian government's revocation of Çelebi's security clearance. Adani has directed Çelebi to immediately hand over all ground handling facilities to ensure uninterrupted operations. The company assures seamless service continuity through new ground handling agencies and states that all existing Çelebi employees at these airports will be transferred to the new agencies under their current employment terms. Adani emphasizes its commitment to maintaining high service standards and prioritizing national interest. (PC: The Telegraph)

U.S. President Donald Trump revealed that India has proposed a trade deal to eliminate tariffs on 60% of American goods, aiming to lower India’s average tariff from nearly 13% to under 4%. Speaking at a business event, Trump highlighted that India is willing to charge “basically no tariff” on many U.S. products. This offer is part of ongoing negotiations to address trade imbalances and avoid U.S. reciprocal tariffs affecting various sectors. The Indian government has not yet officially commented on the proposal, but it signals a potential boost in India-U.S. economic relations. (PC: File Photo)  

Shares of China's Avic Chengdu Aircraft, makers of the J-10 jets used by Pakistan, plunged 9.31% on May 13 following Prime Minister Modi’s bold speech on the success of Operation Sindoor. The strike, targeting terror camps inside Pakistan, was lauded domestically, sparking a rally in Indian defence stocks. Modi declared that any future terror threats would meet annihilation. Meanwhile, Dassault Aviation, the Rafale jet manufacturer, saw a rebound in its stock after earlier declines. Operation Sindoor marks a strategic shift in India’s counter-terror posture, with precision strikes gaining market and geopolitical traction. (PC: AFP)

U.S. President Donald Trump's recent executive order aims to slash American prescription drug prices by 30–80% through a "most favored nation" pricing strategy, aligning U.S. costs with those in other developed nations. While this move seeks to alleviate domestic healthcare expenses, it has raised significant concerns in India. The Global Trade Research Initiative warns that pharmaceutical companies might offset U.S. revenue losses by increasing drug prices in lower-cost markets like India, potentially impacting drug affordability and access. Indian pharmaceutical stocks have already felt the tremors, with notable declines observed in companies heavily reliant on U.S. exports, such as Sun Pharma and Biocon. As the U.S. constitutes a substantial portion of India's pharmaceutical export market, the ripple effects of this policy could be profound, underscoring the interconnectedness of global drug pricing and the delicate balance between affordability and profitability. (PC: Aeon & The Indian Express)

India is considering imposing import duties on select U.S. products in response to Washington's tariffs on steel and aluminium imports, according to a document submitted to the World Trade Organization (WTO) on May 12, 2025. The U.S. initially introduced these tariffs, including a 25% levy on steel, in 2018 under President Donald Trump's administration, which have since been extended. India, the world's second-largest crude steel producer, stated that these U.S. measures affect $7.6 billion worth of Indian exports. In retaliation, India is planning targeted tariff increases on unspecified U.S. products. Additionally, the U.S. has threatened to impose 26% reciprocal tariffs on Indian goods. Amid ongoing trade negotiations, New Delhi has offered to reduce the tariff disparity with the U.S. by two-thirds. The dispute unfolds as India also imposed a 12% temporary tariff on steel imports, primarily targeting cheap imports from China, to support its domestic industry. Simultaneously, India is pursuing trade talks with various partners to boost access for its steel exports. (PC: The Statesman & Reuters)

Indian stock markets opened sharply higher on Monday, with the Sensex jumping 1,793 points to 81,248.20 and the Nifty rising 553 points to 24,561.25. This marks the first trading session since the India-Pakistan ceasefire agreement. Experts say easing border tensions and strong investor confidence led to the rally. Market analyst Ajay Bagga noted that Indian markets have bounced back from recent conflict-related losses. Positive global cues, including productive US-China trade talks, also boosted sentiment. Meanwhile, gold prices dipped over 2%, and oil and US dollar values climbed. The market's strong start reflects optimism in the wake of de-escalation. (PC: PTI)

Following a recent ceasefire agreement between India and Pakistan, market analysts anticipate a potential stabilization in Indian equities. The truce, brokered after escalating tensions due to cross-border skirmishes and military operations, aims to de-escalate the situation along the Line of Control. While the ceasefire may alleviate immediate geopolitical concerns, its durability remains uncertain, and investors are advised to remain cautious. The Indian stock market's response on Monday will likely hinge on the perceived stability of this ceasefire and any further developments in the region. Renewed tensions could negatively impact investor sentiment. (PC: Mint)

The UK-India Free Trade Agreement brings major gains for the Scotch whisky industry. India will cut import taxes on Scotch from 150% to 40% over 10 years, making UK whisky much more affordable in the world’s largest whisky market.   This move is expected to boost exports by £1 billion in five years and create 1,200 jobs across the UK. Mark Kent, Chief Executive of the Scotch Whisky Association, called it “a once-in-a-generation opportunity” for growth. More small and medium UK whisky producers can now access the Indian market, reaching millions of new consumers. (Representative image)

The UK-India Free Trade Agreement is a major win for British producers of food, drink, and medical devices. India will cut tariffs on popular UK exports like chocolate, biscuits, salmon, and soft drinks, making them more affordable in the world’s fastest-growing market. This gives UK brands the chance to reach millions of new Indian consumers, especially as demand for premium imported products rises.   At the same time, the deal reduces tariffs on UK medical devices such as surgical tools and diagnostics equipment. The agreement also supports smooth customs processes and digital trade systems—benefits especially valuable for small and mid-sized exporters.   With India’s healthcare and consumer sectors growing rapidly, the deal is expected to unlock billions in trade, boost UK jobs, and strengthen economic ties. (PC: Representative)

The UK and India have signed a major Free Trade Agreement that will help both economies grow. The deal removes or reduces import taxes (tariffs) on 90% of UK products sold to India. This includes big British exports like Scotch whisky, beauty products, medical devices, and cars. For example, whisky tariffs will fall from 150% to 40% over 10 years, creating more jobs and boosting exports by up to £1 billion. British-made medical and cosmetic products will become cheaper in India, helping small businesses grow. Car tariffs will also drop sharply. The deal is expected to add £4.8 billion to the UK economy and increase wages by £2.2 billion every year. Prime Minister Keir Starmer said, “This landmark deal with India will grow the economy and deliver for British people and businesses. It’s a win for workers, exporters, and consumers.” It’s the UK’s biggest trade deal since Brexit. (PC: Sky News)